Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Maximizing cash back on utilities is achievable with the right strategies. Learn how to enhance your rewards and save on utility bills.
22,571 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
The world’s second richest person title is a moving target as stock prices swing. Here's who holds it this week and w...
A well-known reality TV figure reveals how convincing fake security texts lured him into a crypto scam that wiped out...
Bitcoin is pulling back from its peak, a move many investors fear. History, though, suggests cycles, patience, and di...
A new, secretive cargo delivery concept tested by SpaceX could reshape global logistics. This investor-focused overvi...
A couple wired $40,000 for renovations that never materialized, receiving only a single wall painted. This story high...
Anthropic’s looming IPO could reshape AI investing. With a private valuation near the hundreds of billions and big te...
Micron stock retreats after a spring rally, renewing the debate over whether the memory chip maker has peaked. Analys...
Geopolitical flare-ups around the Strait of Hormuz have sparked a fresh wave of market jitters as the facade U.S.-Ira...
Celebrity beauty routines meet real-life budgeting. This article digs into Hilary Duff's candid take on her go-to tre...
Jim Cramer's latest remarks position Broadcom as a compass for market turning points. As AI demand drives chipmakers,...
Christopher Nolan’s The Odyssey opened to $264 million worldwide, surpassing a $250 million budget and signaling how ...